FATE Operating Cash Flow (Statement)
Fate Therapeutics Inc · Operating Cash Flow (Statement)
FATE Operating Cash Flow (Statement)
Latest reported-$23.43Mperiod ending
FATE Quarterly Cash from Operations (-$2.77M → -$23.43M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
FATE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -23,434,000 | |
| -30,822,000 | |
| -23,314,000 | |
| -24,374,000 | |
| -24,587,000 | |
| -33,809,000 | |
| -27,799,000 | |
| -29,419,000 | |
| -32,306,000 | |
| -33,350,000 | |
| -36,637,000 | |
| -38,273,000 | |
| -28,493,000 | |
| -28,860,000 | |
| -75,389,000 | |
| -55,047,000 | |
| -53,159,000 | |
| -64,613,000 | |
| -70,293,000 | |
| -33,375,000 | |
| -32,106,000 | |
| -27,096,000 | |
| -20,664,000 | |
| -30,733,000 | |
| 38,841,000 | |
| -26,673,000 | |
| -25,535,000 | |
| -19,838,000 | |
| -20,309,000 | |
| -17,493,000 | |
| -11,020,000 | |
| -3,556,000 | |
| -11,523,000 | |
| -12,551,000 | |
| -10,721,000 | |
| -9,857,000 | |
| -8,872,000 | |
| -7,455,000 | |
| -7,551,000 | |
| -7,516,000 | |
| -7,504,000 | |
| -7,252,000 | |
| -6,970,000 | |
| -7,131,000 | |
| 2,079,000 | |
| -6,375,000 | |
| -6,154,000 | |
| -5,521,000 | |
| -5,489,000 | |
| -5,255,000 | |
| -4,578,000 | |
| -3,472,000 | |
| -3,390,000 | |
| -3,933,000 | |
| -3,394,000 | |
| -2,768,000 |